13 result(s)
-
1.
Abbott Molecular Inc. (Re) - 2021 CACP 19 - 2021-05-04
PatentsSubject Matter (part 1) - Mental Steps
-
2.
ACKLEY MACHINE CORPORATION (Re) - 2023 CACP 2 - 2023-01-12
PatentsApplication for Patent - Amendment to - New Matter
Claims - Ambiguity or Indefiniteness (incomplete)
Disclosure - Adequacy or Deficiency of Description
Obviousness - Obviousness
-
3.
Acoustic L.P. (Re) - 2021 CACP 39 - 2021-08-23
PatentsSubject Matter (part 1) - Computer Programs
Subject Matter (part 1) - Meaning of Art
Subject Matter (part 1) - Mental Steps
-
4.
-
5.
Alexion Pharmaceuticals, Inc. (Re) - 2021 CACP 41 - 2021-09-09
PatentsSubject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of
-
6.
Amazon Technologies, Inc. (Re) - 2020 CACP 28 - 2020-07-13
PatentsSubject Matter (part 1) - Meaning of Art
Subject Matter (part 1) - Mere Plan
-
7.
Amazon Technologies Inc. (Re) - 2021 CACP 11 - 2021-03-25
PatentsDisclosure - Adequacy or Deficiency of Description
Obviousness - Obviousness
-
8.
Amgen Research (Munich) GmbH (Re) - 2021 CACP 2 - 2021-01-06
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Subject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of
-
9.
-
10.
-
11.
-
12.
Armagen Inc. (Re) - 2023 CACP 8 - 2023-03-02
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Claims - Excessive Width - Not Supported by Disclosure
Disclosure - Adequacy or Deficiency of Description
Novelty
Obviousness - Obviousness
Subject Matter (part 1) - Professional or Artistic Skill
-
13.
Astellas Institute for Regenerative Medicine - 2023 CACP 26 - 2023-11-29
PatentsApplication for Patent - Amendment to - New Matter
Disclosure - Adequacy or Deficiency of Description
Utility - Utility